Vaping Changes Oral Bacteria Differently Than Cigarettes

Vaping does not return your mouth to a never-smoker baseline. The best current review finds that e-cigarette users tend to have oral bacterial communities that differ from both never-smokers and cigarette smokers. That does not prove vaping causes periodontal disease or oral cancer. It does mean that "no combustion" is a poor shortcut for "microbiologically harmless."

A 2026 systematic review by La Rosa et al. assessed 12 clinical studies of e-cigarette use and the oral microbiome. Across saliva, subgingival plaque, and oral mucosal samples, the more consistent finding involved beta diversity: the overall mix of bacteria differed in e-cigarette users compared with never-smokers, and in several studies compared with cigarette smokers. The review rated the certainty of evidence as very low for every primary outcome. That rating does not erase the signal; it means the available studies cannot yet support firm clinical conclusions.

A different microbial state, not an intermediate one

Microbiome research often reports two broad measures. Alpha diversity asks how rich and even the bacterial community is within a single sample. Beta diversity asks whether communities differ in composition between groups. Vaping's signal appears stronger for the second question.

Several studies found no meaningful alpha-diversity difference between e-cigarette users and never-smokers. In other words, vaping has not been shown to empty the mouth of bacterial species in the way a major antibiotic exposure can. But a similar number of kinds of bacteria can still form a different community, with different organisms taking up more space.

That distinction appeared in the clinically relevant territory below the gumline. In a cross-sectional study of subgingival plaque, Thomas et al. (2022) identified a periodontal microbiome in e-cigarette users that differed from both conventional smokers and never-smokers. Because subgingival plaque sits at the site where periodontitis develops, it is more informative for gum disease than a saliva sample alone. It remains an observational snapshot, however: it cannot establish whether vaping created the microbiome pattern or whether pre-existing differences helped shape who used e-cigarettes.

Saliva studies point in the same general direction. Chopyk et al. (2021) reported compositional differences between e-cigarette users and non-users, and Yang et al. (2023) independently found group-level salivary differences. A 2025 pilot comparison by Liu et al. likewise found that e-cigarette users and cigarette smokers had divergent oral microbiome outcomes. The pilot design limits how far that result can travel, but it challenges the simple story that vaping merely produces a weaker version of smoking's oral effects.

The bacteria that draw attention

The systematic review reported enrichment of Fusobacterium, Veillonella, and Leptotrichia in e-cigarette users relative to never-smokers in the studies that detected taxonomic differences. Fusobacterium matters because it has established links to periodontal disease progression and has been implicated in oral cancer biology. It does not follow that a higher relative abundance of this genus predicts an individual's cancer risk. A genus is not a diagnosis, and a microbiome association is not a cancer-incidence study.

Xu et al. (2022) provide a little more temporal evidence than the field usually has. Their study measured participants at two visits and reported enrichment of recognized periodontal pathogens with continued e-cigarette use. Two time points do not map a long-term trajectory, but the design is more helpful than a one-time comparison for asking whether the pattern tracks with exposure.

Sample location also changes the result. Saliva, cheek or mucosal swabs, and subgingival plaque are different habitats with different oxygen levels, nutrients, immune contact, and physical structure. The variation between studies therefore may reflect biology as well as different sequencing methods and analytic pipelines. Treating every oral sample as interchangeable would make the science look tidier than it is.

What could drive the shift?

Combustion is absent from e-cigarettes, but aerosol chemistry is not. A 2025 laboratory study by Beverly et al. used untargeted metabolomics in in-vitro co-incubations of e-cigarette aerosol and indigenous oral microbial communities. The microbes actively metabolized aerosol components, and the communities changed structurally and functionally. That result supports a plausible mechanism: propylene glycol, vegetable glycerin, and flavoring chemicals may act as selective inputs to an oral biofilm rather than inert delivery fluid.

An umbrella review by Panariello et al. (2025) reached a compatible interpretation, concluding that the propylene glycol/vegetable glycerin matrix may disrupt biofilm structure and increase pathogen adherence independently of nicotine or flavorings. "May" matters here. The central mechanistic evidence comes from laboratory models, not controlled exposure studies in living mouths. Saliva flow, diet, brushing, immune activity, epithelial cells, and the rest of ordinary human messiness could alter the effect substantially.

The available evidence also cannot tell readers whether nicotine-free products spare the oral microbiome. Researchers have not adequately separated nicotine's contribution from that of the vehicle chemicals and flavorings. The hypothesis that nicotine-free vaping carries similar microbial effects is plausible, not demonstrated.

The clinical endpoint is early, not final

The most direct bridge from microbiome measurements to oral health comes from Park et al. (2023). Using mediation analysis of saliva and subgingival sites, the researchers modeled the oral microbiome as a mediator between e-cigarette use and measured gingival inflammation. This goes beyond simply observing that two groups have different bacteria. Still, mediation analysis does not prove a biological chain in the way a randomized intervention could, and gingival inflammation is an early, potentially reversible finding rather than diagnosed periodontitis or clinical attachment loss.

No study in this evidence base shows that vaping-associated microbiome changes cause incident periodontitis, tooth loss, clinical attachment loss, or oral cancer. The cancer question deserves especially careful wording. A 2024 review of e-cigarettes and oral cancer found biologically plausible pathways, including those involving Fusobacterium, but no epidemiological evidence that e-cigarette users have higher oral-cancer incidence because of these microbiome changes.

Why the certainty remains low

Ten of the 12 studies in the 2026 systematic review were cross-sectional. Most therefore cannot separate cause from selection: people may have had different oral microbiomes before they began vaping. The literature also struggles with dual use and prior smoking. Many e-cigarette users are current cigarette smokers or former smokers, and combustible tobacco changes the oral microbiome in its own right. Inadequate control for either exposure can blur the e-cigarette-specific result.

Studies also define "e-cigarette user" inconsistently. Frequency, duration, device type, nicotine concentration, and flavoring vary, often without enough detail to compare studies cleanly. Add different sample sites, sequencing platforms, and statistical methods, and the very-low GRADE rating becomes understandable. It is a warning against certainty, not permission to ignore repeated findings.

Vaping appears to shift oral bacterial communities in a distinct direction. Researchers have not yet measured the long-term disease burden that shift creates.

What to do with this now

If someone switches completely from cigarettes to e-cigarettes, broader harm-reduction questions require evidence beyond the oral microbiome. This research does not establish that vaping causes the same oral harm as smoking, and it should not be used to make that claim. It does remove any basis for assuming that vaping leaves oral ecology untouched.

For frequent or long-term e-cigarette users, regular dental and periodontal care is a sensible precaution, especially if gums bleed, swell, recede, or remain tender. The decisive missing studies are prospective cohorts and controlled exposure research that separate exclusive vaping from dual use and prior smoking, measure product characteristics, and track clinical outcomes after cessation. Until then, the honest conclusion is narrow: vaping changes the oral microbiome differently from smoking, and nobody has yet shown that the change is safe.